Ignite Creation Date:
2025-12-24 @ 9:08 PM
Ignite Modification Date:
2025-12-25 @ 6:58 PM
Study NCT ID:
NCT01548404
Status:
COMPLETED
Last Update Posted:
2018-08-10
First Post:
2012-03-05
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study of Dupilumab in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Sponsor:
Regeneron Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-04
Start Date Type:
None
Primary Completion Date:
2013-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-06
Completion Date Type:
ACTUAL
First Submit Date:
2012-03-05
First Submit QC Date:
None
Study First Post Date:
2012-03-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-05-22
Results First Submit QC Date:
None
Results First Post Date:
2018-08-10
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2015-09-11
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2017-11-13
Last Update Post Date:
2018-08-10
Last Update Post Date Type:
ACTUAL